These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12571668)

  • 1. Nutrient intake in women with primary and secondary Sjögren's syndrome.
    Cermak JM; Papas AS; Sullivan RM; Dana MR; Sullivan DA
    Eur J Clin Nutr; 2003 Feb; 57(2):328-34. PubMed ID: 12571668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
    Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
    Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
    Ampélas JF; Wattiaux MJ; Van Amerongen AP
    Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosemantics guided gene expression profiling of Sjögren's syndrome: a comparative analysis with systemic lupus erythematosus and rheumatoid arthritis.
    Shah NR; Noll BD; Stevens CB; Brennan MT; Mougeot FB; Mougeot JC
    Arthritis Res Ther; 2017 Aug; 19(1):192. PubMed ID: 28818099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.
    Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM
    Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum 14-3-3η protein is associated with clinical and serologic features of Sjögren's syndrome in patients with systemic lupus erythematosus: a cross-sectional analysis.
    Hammam N; Gamal NM; Elzohri MH; Elsonbaty AM; Rashed AM; Eldaly ZH; Tarik D; Gheita TA
    Clin Rheumatol; 2020 Sep; 39(9):2603-2610. PubMed ID: 32206972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus.
    Witte T; Matthias T; Arnett FC; Peter HH; Hartung K; Sachse C; Wigand R; Braner A; Kalden JR; Lakomek HJ; Schmidt RE
    J Rheumatol; 2000 Nov; 27(11):2617-20. PubMed ID: 11093442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired degradation and aberrant phagocytosis of necrotic cell debris in the peripheral blood of patients with primary Sjögren's syndrome.
    Fragoulis GE; Vakrakou AG; Papadopoulou A; Germenis A; Kanavakis E; Moutsopoulos HM; Manoussakis MN
    J Autoimmun; 2015 Jan; 56():12-22. PubMed ID: 25228497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutrient intake and diet quality in patients with systemic lupus erythematosus on a culturally sensitive cholesterol lowering dietary program.
    Shah M; Adams-Huet B; Kavanaugh A; Coyle Y; Lipsky P
    J Rheumatol; 2004 Jan; 31(1):71-5. PubMed ID: 14705221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Assessment of Hand Joint Ultrasound Findings in Symptomatic Patients with Systemic Lupus Erythematosus and Sjögren's Syndrome: A Pilot Study.
    Lei L; Morgan S; Ntatsaki E; Ciurtin C
    Ultrasound Med Biol; 2019 Feb; 45(2):452-460. PubMed ID: 30401509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical and laboratory characteristics of Sjögren's syndrome that progresses to systemic lupus erythematosus: a retrospective case-control study.
    Yang Y; Li Z; Wang L; Zhang F
    Int J Rheum Dis; 2013 Apr; 16(2):173-7. PubMed ID: 23773641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of dendritic cell immunoreceptor (DCIR) polymorphisms in susceptibility of systemic lupus erythematosus and primary Sjogren's syndrome.
    Liu M; Wu X; Liu X; He J; Su Y; Guo J; Li Z
    Hum Immunol; 2015 Nov; 76(11):808-11. PubMed ID: 26429306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
    Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ
    Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nailfold capillary abnormalities in patients with Sjögren's syndrome and systemic lupus erythematosus.
    Ohtsuka T
    Br J Dermatol; 1997 Jan; 136(1):94-6. PubMed ID: 9039302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, serologic, and genetic profiles of patients with associated Sjögren's syndrome and systemic lupus erythematosus.
    Szanto A; Szodoray P; Kiss E; Kapitany A; Szegedi G; Zeher M
    Hum Immunol; 2006 Nov; 67(11):924-30. PubMed ID: 17145372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between anti-Ro (SS-A) antibody-positive Sjögren's syndrome and anti-Ro (SS-A) antibody-positive lupus erythematosus.
    Provost TT; Talal N; Harley JB; Reichlin M; Alexander E
    Arch Dermatol; 1988 Jan; 124(1):63-71. PubMed ID: 3257371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic significance of immunohistological skin examination in patients with primary Sjögren's syndrome and other chronic inflammatory connective tissue diseases.
    Oxholm P; Oxholm A; Manthorpe R
    Scand J Rheumatol Suppl; 1986; 61():173-6. PubMed ID: 3296145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased levels of circulating DNA in patients with systemic autoimmune diseases: A possible marker of disease activity in Sjögren's syndrome.
    Bartoloni E; Ludovini V; Alunno A; Pistola L; Bistoni O; Crinò L; Gerli R
    Lupus; 2011 Aug; 20(9):928-35. PubMed ID: 21613330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
    Goules A; Tzioufas AG; Manousakis MN; Kirou KA; Crow MK; Routsias JG
    J Autoimmun; 2006 May; 26(3):165-71. PubMed ID: 16621447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A BAFF receptor His159Tyr mutation in Sjögren's syndrome-related lymphoproliferation.
    Papageorgiou A; Mavragani CP; Nezos A; Zintzaras E; Quartuccio L; De Vita S; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M
    Arthritis Rheumatol; 2015 Oct; 67(10):2732-41. PubMed ID: 26097183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.